CLDI, CLDWW · CIK 0001855485 · operating
Calidi Biotherapeutics, Inc. (CLDI) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the NYSE. With a market capitalization of $6 million, Calidi Biotherapeutics, Inc. is a micro-cap company. The stock currently trades at $0.84, up 5.93% today, with a 52-week range of $0.72–$19.20. The company trades at a trailing P/E of 2.3x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.97 | $-2.97 | -271.7% | |
| 2023 | $1.73 | $1.73 | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — |